OmniVision Integrated Circuits Group, Inc. (SHA:603501)

Market Cap	149.16B
Revenue (ttm)	26.56B
Net Income (ttm)	3.63B
Shares Out	1.20B
EPS (ttm)	3.03
PE Ratio	40.94
Forward PE	30.32
Dividend	0.44 (0.36%)
Ex-Dividend Date	Aug 1, 2025

Volume	23,150,122
Average Volume	15,159,571
Open	124.50
Previous Close	124.19
Day's Range	122.81 - 126.30
52-Week Range	81.41 - 161.96
Beta	1.08
RSI	54.02
Earnings Date	Aug 30, 2025

About Achilles Therapeutics

OmniVision Integrated Circuits Group, Inc. a semiconductor design company, provides sensor solutions, analog solutions and touch screen and display solutions. The company offers application specific integrated circuits, power management devices, diodes, FETs, triode BJTs, protective devices, low noise amplifiers, RF switches, tuners, image sensors, signal circuits, audio devices, touch and display solutions, and microcontrollers. Its products are used in mobile phones, security, automotive electronics, wearable devices, IoT, communications, com...

• Industry: Semiconductors
• Sector: Technology
• Founded: 1995
• Employees: 5,376
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603501

Financial Performance

In 2024, SHA:603501's revenue was 25.73 billion, an increase of 22.41% compared to the previous year's 21.02 billion. Earnings were 3.32 billion, an increase of 498.11%.